4.5 Article

Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Gastroenterology & Hepatology

Yes-Associated Protein Up-regulates Jagged-1 and Activates the NOTCH Pathway in Human Hepatocellular Carcinoma

Darjus Felix Tschaharganeh et al.

GASTROENTEROLOGY (2013)

Review Cell Biology

YAP oncogene overexpression supercharges colon cancer proliferation

Joseph Avruch et al.

CELL CYCLE (2012)

Editorial Material Pharmacology & Pharmacy

An update on targeting Hippo-YAP signaling in liver cancer

Angela M. Liu et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2012)

Article Oncology

YAP is a candidate oncogene for esophageal squamous cell carcinoma

Tomoki Muramatsu et al.

CARCINOGENESIS (2011)

Article Biochemistry & Molecular Biology

The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene

X. Zhang et al.

ONCOGENE (2011)

Review Oncology

Current and emerging treatment options in triple-negative breast cancer

Omer Dizdar et al.

ONCOLOGY REVIEWS (2010)

Article Biochemistry & Molecular Biology

YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease

Kainan Wang et al.

BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2009)

Article Cell Biology

The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila

S Pantalacci et al.

NATURE CELL BIOLOGY (2003)